PRCT Procept Biorobotics Corp

$21.70 +3.83%

Healthcare · Surgical & Medical Instruments & Apparatus

Procept Biorobotics Corp (PRCT) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $1.2 billion. Shares last traded at $21.70, 65.1% below their 52-week high. Over the past year the stock is down 63.2%. Net profit margin is -0.0%, above the peer median of -7.6%. Revenue grew 37.2% year over year.

Market Cap

$1.2B

Shares Out

56.9M

EPS (TTM)

$-3.00

P/E Ratio

—

P/S Ratio

4.01

P/B Ratio

3.55

Dividend / Share

—

Dividend Yield

—

52-Week High

$62.18

52-Week Low

$19.38

Volume

104,373

Avg Vol (3m)

82,648.492

Performance

-21.69%

-16.15%

-15.50%

-39.11%

YTD

-29.38%

-63.23%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

35.01

SMA (50)

$25.64

SMA (200)

$29.98

Price vs SMA50

-15.36%

Price vs SMA200

-27.63%

ATR (14)

$1.78

Financials

Revenue

$308M

Net Income

$-0M

Gross Margin

63.7%

Operating Margin

-33.7%

Net Margin

-0.0%

Return on Equity

-0.0%

Return on Assets

-0.0%

Current Ratio

6.73

Debt / Equity

0.15

Revenue Growth (YoY)

+37.2%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.56	2026-04-30
FY 2025	$-1.72	2026-02-26
Q3 2025	$-1.19	2025-11-05
Q2 2025	$-0.80	2025-08-07
Q1 2026	$-0.45	2026-04-30
FY 2025	$-1.75	2026-02-26

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

PRCT vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

4.01 / 2.52 med

+59% premium

Net margin vs peers

-0.0% / -7.6% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.